Results of phase i study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy

Journal of Neuro-Oncology

Volumn 108, Issue 3, 2012, Pages 521-525

  McPherson, Christopher M ^a,b,c   Gerena Lewis, Margie ^a   Breneman, John C ^a,b   Warnick, Ronald E ^a,b,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c MAYFIELD CLINIC   (United States)

Author keywords

BCNU wafers; Glioblastoma multiforme; I 125 seeds; Newly diagnosed; Radiation toxicity

Indexed keywords

BEVACIZUMAB; CARMUSTINE; IODINE 125; STEROID; TEMOZOLOMIDE;

ADULT; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONFERENCE PAPER; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG IMPLANTATION; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHASE 1 CLINICAL TRIAL; POSTOPERATIVE CARE; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECURRENT CANCER; SURVIVAL TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARMUSTINE; CHEMORADIOTHERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84864060473     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0854-z     Document Type: Conference Paper

References (16)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, La-combe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. NEJM 352:987-996 (Pubitemid 40349501)
2. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y (1983) Compar-ison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary man-agement of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 52:997-1007 (Pubitemid 13050763)
3. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of416 patients with glioblastoma multiforme: prognosis, extent ofresection, and survival. J Neurosurg 95:190-198 (Pubitemid 32799739)
4. Hochberg FH, Pruitt A (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30:907-911 (Pubitemid 10059239)
5. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G et al (1995) Placebo-con-trolled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recur-rent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 345:1008-1012
6. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jaaskelainen J, Ram Z (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant gli-oma. Neuro Oncol 5:79-88 (Pubitemid 36422560)
7. Patel S, Breneman JC, Warnick RE, Albright RE Jr, Tobler WD, van Loveren HR, Tew JM Jr (2000) Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme. Neurosurgery 46:1123-1128
8. Dagnew E, Kanski J, McDermott MW, Sneed PK, McPherson CM, Breneman JC, Warnick RE (2007) Management of newly diagnosed single brain metastasis with surgical resection and permanent I-125 seeds without whole brain radiotherapy: a two institution experience. Neurosurg Focus 22(3):E3
9. Ewend MG, Williams JA, Tabassi K, Tyler BM, Babel KM, Anderson RC, Pinn ML, Brat DJ, Brem H (1996) Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models. Cancer Res 56:5217-5223 (Pubitemid 26383039)
10. Darakchiev BJ, Albright RE, Breneman JC, Warnick RE (2008) Safety and efficacy ofpermanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multi-forme. J Neurosurg 108:236-242 (Pubitemid 351213285)
11. McPherson CM, Warnick RE (2004) Permanent low activity I-125 interstitial implants as an adjuvant therapy for the treatment of newly diagnosed glioblastoma multiforme. Poster AANS Annual Meeting, Orlando
12. MacDonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. JCO 8:1277-1280 (Pubitemid 20195640)
13. Selker RG, Shapiro WR, Burger P, Blackwood MS (2002) The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51:343-355
14. Chen AM, Chang S, Pouliot J, Sneed PK, Prados MD, Lamborn KR, Malec MK, McDermott MW, Berger MS, Larson DA (2007) Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 69:825-830 (Pubitemid 47418399)
15. Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ Jr (2004) Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60:853-860 (Pubitemid 39311766)
16. Villavicencio AT, Burneikiene S, Romanelli P, Fariselli L, McNeely L, Lipani JD, Chang SD, Nelson EL, McIntyre M, Broggi G, Adler JR Jr (2009) Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: a multicenter experience. Neurosurg Rev 32:417-424